• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于乳腺癌鉴别诊断的 radiomiRNomic 特征定义方法。

Approach for the Definition of radiomiRNomic Signatures for Breast Cancer Differential Diagnosis.

机构信息

Institute of Molecular Bioimaging and Physiology, National Research Council (IBFM-CNR), Via F. Cervi 93, 20090 Segrate-Milan, Milan, Italy.

Laboratory of Nanomedicine and Molecular Imaging, Istituti Clinici Scientifici Maugeri IRCCS, via Maugeri 4, 27100 Pavia, Italy.

出版信息

Int J Mol Sci. 2019 Nov 20;20(23):5825. doi: 10.3390/ijms20235825.

DOI:10.3390/ijms20235825
PMID:31756987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6929037/
Abstract

UNLABELLED

Personalized medicine relies on the integration and consideration of specific characteristics of the patient, such as tumor phenotypic and genotypic profiling.

BACKGROUND

Radiogenomics aim to integrate phenotypes from tumor imaging data with genomic data to discover genetic mechanisms underlying tumor development and phenotype.

METHODS

We describe a computational approach that correlates phenotype from magnetic resonance imaging (MRI) of breast cancer (BC) lesions with microRNAs (miRNAs), mRNAs, and regulatory networks, developing a radiomiRNomic map. We validated our approach to the relationships between MRI and miRNA expression data derived from BC patients. We obtained 16 radiomic features quantifying the tumor phenotype. We integrated the features with miRNAs regulating a network of pathways specific for a distinct BC subtype.

RESULTS

We found six miRNAs correlated with imaging features in Luminal A (, , , , , and ), seven miRNAs (, , , , , , and ) in HER2+, and two miRNAs ( and ) in Basal subtype. We demonstrate that the combination of correlated miRNAs and imaging features have better classification power of Luminal A versus the different BC subtypes than using miRNAs or imaging alone.

CONCLUSION

Our computational approach could be used to identify new radiomiRNomic profiles of multi-omics biomarkers for BC differential diagnosis and prognosis.

摘要

未加标签

个性化医学依赖于整合和考虑患者的特定特征,如肿瘤表型和基因型分析。

背景

放射组学旨在整合肿瘤影像学数据与基因组数据中的表型,以发现肿瘤发生和表型的遗传机制。

方法

我们描述了一种计算方法,该方法将乳腺癌(BC)病变的磁共振成像(MRI)中的表型与 microRNAs(miRNAs)、mRNAs 和调控网络相关联,从而构建一个 radiomiRNomic 图谱。我们验证了我们的方法与从 BC 患者获得的 MRI 和 miRNA 表达数据之间的关系。我们获得了 16 个定量肿瘤表型的放射组学特征。我们将这些特征与调控特定 BC 亚型特定途径网络的 miRNA 进行了整合。

结果

我们发现了六个与 Luminal A(、、、、、和)成像特征相关的 miRNA,七个与 HER2+相关的 miRNA(、、、、、、和),以及两个与 Basal 亚型相关的 miRNA(和)。我们证明,与单独使用 miRNA 或成像特征相比,相关 miRNA 和成像特征的组合对 Luminal A 与不同 BC 亚型的分类能力更好。

结论

我们的计算方法可用于识别 BC 多组学生物标志物的新 radiomiRNomic 图谱,用于鉴别诊断和预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/69d34a9deb5f/ijms-20-05825-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/cc5a9089a76d/ijms-20-05825-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/c29546e653be/ijms-20-05825-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/be6ccac304d4/ijms-20-05825-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/d89c655b96bb/ijms-20-05825-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/ef6fc45b5f8d/ijms-20-05825-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/69d34a9deb5f/ijms-20-05825-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/cc5a9089a76d/ijms-20-05825-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/c29546e653be/ijms-20-05825-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/be6ccac304d4/ijms-20-05825-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/d89c655b96bb/ijms-20-05825-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/ef6fc45b5f8d/ijms-20-05825-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/747c/6929037/69d34a9deb5f/ijms-20-05825-g006.jpg

相似文献

1
Approach for the Definition of radiomiRNomic Signatures for Breast Cancer Differential Diagnosis.用于乳腺癌鉴别诊断的 radiomiRNomic 特征定义方法。
Int J Mol Sci. 2019 Nov 20;20(23):5825. doi: 10.3390/ijms20235825.
2
Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.分泌型乳腺肿瘤间质液 microRNAs 及其靶基因与三阴性乳腺癌、肿瘤分级和免疫浸润相关。
Breast Cancer Res. 2020 Jun 30;22(1):73. doi: 10.1186/s13058-020-01295-6.
3
Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer.mRNA 和 miRNA 谱的综合分析揭示了 miR-193 和 miR-210 作为不同乳腺癌分子亚型潜在调控生物标志物的作用。
BMC Cancer. 2021 Jan 18;21(1):76. doi: 10.1186/s12885-020-07731-2.
4
MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer.微小RNA:乳腺癌诊断、预后、治疗预测的新型生物标志物及治疗工具
Theranostics. 2015 Jul 13;5(10):1122-43. doi: 10.7150/thno.11543. eCollection 2015.
5
MiR-190b, the highest up-regulated miRNA in ERα-positive compared to ERα-negative breast tumors, a new biomarker in breast cancers?与雌激素受体α(ERα)阴性乳腺癌相比,MiR-190b是ERα阳性乳腺癌中上调程度最高的微小RNA,它会是乳腺癌中的一种新生物标志物吗?
BMC Cancer. 2015 Jul 5;15:499. doi: 10.1186/s12885-015-1505-5.
6
Candidate miRNAs in human breast cancer biomarkers: a systematic review.人类乳腺癌生物标志物中的候选 miRNA:系统评价。
Breast Cancer. 2018 Mar;25(2):198-205. doi: 10.1007/s12282-017-0814-8. Epub 2017 Nov 3.
7
DNA methylation contributes to deregulation of 12 cancer-associated microRNAs and breast cancer progression.DNA甲基化导致12种癌症相关微小RNA的失调及乳腺癌进展。
Gene. 2017 Mar 10;604:1-8. doi: 10.1016/j.gene.2016.12.018. Epub 2016 Dec 18.
8
The potential of miRNAs for diagnosis, treatment and monitoring of breast cancer.微小RNA在乳腺癌诊断、治疗及监测中的潜力。
Scand J Clin Lab Invest Suppl. 2016;245:S34-9. doi: 10.1080/00365513.2016.1208444. Epub 2016 Jul 19.
9
Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.竞争性内源性RNA网络分析确定了不同乳腺癌亚型中的关键基因。
Oncotarget. 2017 Feb 7;8(6):10171-10184. doi: 10.18632/oncotarget.14361.
10
Identifying miRNA as biomarker for breast cancer subtyping using association rule.使用关联规则识别 miRNA 作为乳腺癌亚型的生物标志物。
Comput Biol Med. 2024 Aug;178:108696. doi: 10.1016/j.compbiomed.2024.108696. Epub 2024 Jun 3.

引用本文的文献

1
Amino Acid Transporters in Glioblastoma: Implications for Diagnosis, Disease Monitoring, Therapeutic Targeting, and Drug Delivery.胶质母细胞瘤中的氨基酸转运体:对诊断、疾病监测、治疗靶点及药物递送的意义
Mol Diagn Ther. 2025 Aug 22. doi: 10.1007/s40291-025-00810-9.
2
Radiogenomic Landscape of Metastatic Endocrine-Positive Breast Cancer Resistant to Aromatase Inhibitors.对芳香化酶抑制剂耐药的转移性内分泌阳性乳腺癌的放射基因组学特征
Cancers (Basel). 2025 Feb 26;17(5):808. doi: 10.3390/cancers17050808.
3
Radiogenomics: bridging the gap between imaging and genomics for precision oncology.

本文引用的文献

1
Theranostic application of in HER2+ breast cancer.在 HER2+ 乳腺癌中的治疗诊断应用。
Theranostics. 2020 Jan 1;10(1):50-61. doi: 10.7150/thno.36274. eCollection 2020.
2
Dynamic Contrast-Enhanced MRI Evaluation of Pathologic Complete Response in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer After HER2-Targeted Therapy.曲妥珠单抗靶向治疗后人类表皮生长因子受体 2(HER2)阳性乳腺癌病理完全缓解的动态对比增强磁共振成像评估。
Acad Radiol. 2020 May;27(5):e87-e93. doi: 10.1016/j.acra.2019.07.011. Epub 2019 Aug 20.
3
Multiparametric MR imaging to assess response following neoadjuvant systemic treatment in various breast cancer subtypes: Comparison between different definitions of pathologic complete response.
放射基因组学:弥合影像学与基因组学之间的差距,实现精准肿瘤学。
MedComm (2020). 2024 Sep 9;5(9):e722. doi: 10.1002/mco2.722. eCollection 2024 Sep.
4
Comparative analysis of Doxycycline and Ayurvedic herbs to target metastatic breast cancer: An approach.多西环素与阿育吠陀草药针对转移性乳腺癌的比较分析:一种方法。
Biomedicine (Taipei). 2024 Jun 1;14(2):74-79. doi: 10.37796/2211-8039.1448. eCollection 2024.
5
A Focus on the Synergy of Radiomics and RNA Sequencing in Breast Cancer.聚焦于放射组学和 RNA 测序在乳腺癌中的协同作用。
Int J Mol Sci. 2023 Apr 13;24(8):7214. doi: 10.3390/ijms24087214.
6
Radiogenomics, Breast Cancer Diagnosis and Characterization: Current Status and Future Directions.放射基因组学、乳腺癌诊断与特征分析:现状与未来方向
Methods Protoc. 2022 Oct 3;5(5):78. doi: 10.3390/mps5050078.
7
Diagnosis Biomarkers of Cholangiocarcinoma in Human Bile: An Evidence-Based Study.人胆汁中胆管癌的诊断生物标志物:一项基于证据的研究。
Cancers (Basel). 2022 Aug 13;14(16):3921. doi: 10.3390/cancers14163921.
8
Radiogenomics analysis reveals the associations of dynamic contrast-enhanced-MRI features with gene expression characteristics, PAM50 subtypes, and prognosis of breast cancer.放射基因组学分析揭示了动态对比增强磁共振成像特征与基因表达特征、PAM50亚型及乳腺癌预后之间的关联。
Front Oncol. 2022 Jul 28;12:943326. doi: 10.3389/fonc.2022.943326. eCollection 2022.
9
Prediction of the clinicopathological subtypes of breast cancer using a fisher discriminant analysis model based on radiomic features of diffusion-weighted MRI.基于扩散加权 MRI 影像组学特征的 Fisher 判别分析模型预测乳腺癌的临床病理亚型。
BMC Cancer. 2020 Nov 9;20(1):1073. doi: 10.1186/s12885-020-07557-y.
10
Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance.脑胶质瘤的分子和细胞复杂性。关注肿瘤微环境和使用分子及影像生物标志物克服治疗抵抗。
Int J Mol Sci. 2020 Aug 6;21(16):5631. doi: 10.3390/ijms21165631.
多参数磁共振成像评估不同乳腺癌亚型新辅助全身治疗后的反应:不同病理完全缓解定义之间的比较。
Eur J Radiol. 2019 Aug;117:132-139. doi: 10.1016/j.ejrad.2019.06.009. Epub 2019 Jun 12.
4
AI-based applications in hybrid imaging: how to build smart and truly multi-parametric decision models for radiomics.基于人工智能的混合成像应用:如何为放射组学构建智能且真正多参数的决策模型。
Eur J Nucl Med Mol Imaging. 2019 Dec;46(13):2673-2699. doi: 10.1007/s00259-019-04414-4. Epub 2019 Jul 11.
5
Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.基于扩散加权成像的影像组学特征评估乳腺癌受体状态和分子亚型。
Mol Imaging Biol. 2020 Apr;22(2):453-461. doi: 10.1007/s11307-019-01383-w.
6
CT-based radiomic signatures for prediction of pathologic complete response in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.基于 CT 的放射组学特征预测食管鳞癌新辅助放化疗后病理完全缓解。
J Radiat Res. 2019 Jul 1;60(4):538-545. doi: 10.1093/jrr/rrz027.
7
Prediction early recurrence of hepatocellular carcinoma eligible for curative ablation using a Radiomics nomogram.使用放射组学列线图预测适合根治性消融的肝细胞癌早期复发。
Cancer Imaging. 2019 Apr 26;19(1):21. doi: 10.1186/s40644-019-0207-7.
8
Machine learning-based radiomic models to predict intensity-modulated radiation therapy response, Gleason score and stage in prostate cancer.基于机器学习的放射组学模型预测前列腺癌调强放疗反应、Gleason 评分和分期。
Radiol Med. 2019 Jun;124(6):555-567. doi: 10.1007/s11547-018-0966-4. Epub 2019 Jan 3.
9
Identification of six key miRNAs associated with breast cancer through screening large-scale microarray data.通过筛选大规模微阵列数据鉴定与乳腺癌相关的六个关键微小RNA。
Oncol Lett. 2018 Oct;16(4):4159-4168. doi: 10.3892/ol.2018.9175. Epub 2018 Jul 19.
10
Background, current role, and potential applications of radiogenomics.放射组学的背景、当前作用和潜在应用。
J Magn Reson Imaging. 2018 Mar;47(3):604-620. doi: 10.1002/jmri.25870. Epub 2017 Nov 2.